Novo Nordisk (NVO) reportedly plans to phase out production of its human insulin pens while it ramps up production of other ...

Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

The University of Pittsburgh is studying ways to improve the lives of Type 2 diabetics, or people who just want to control ...

"I'm using [Ozempic] off-label for a whole host of conditions — and have been for years," Dr. Caroline Messer, an ...

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

Anyone who needs insulin to treat diabetes knows that the cost of the drug has skyrocketed in the last few years. The reason for the sharp ...

This health news summary explores various pharmaceutical developments including Novo Nordisk's phasing out of insulin pens, a ...

The combination of intranasal insulin (INI) and the sodium-glucose cotransporter ... Metabolic and vascular disorders are ...

Allie Goecke-Butler didn't choose to get diabetes at 24 and become insulin dependent, but yet she says, "staying alive is becoming more and more expensive." ...

Medicare Advantage Special Needs Plans now make up more than a quarter of all enrollments. Learn more about what they are and ...

Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...

A study of Gila monster venom helped start the revolution in weight-loss drugs. But scientists think that’s just the ...